Session Sponsored by Global Down Syndrome Foundation | S13. Down Syndrome Regression Disorder: New Frontiers in Biomarkers, Phenotypes, and Clinical Trials
Tracks
Room 1 | Capitol Ballroom
| Friday, June 19, 2026 |
| 9:30 - 11:30 |
| Room 1 | Capitol Ballroom |
Speaker
Dr. Jonathan Santoro
Director of Neuroimmunology
Children's Hospital Los Angeles and the Keck School of Medicine of the University of Southern California
Introduction
9:30 - 9:35
Dr Cathy Franklin
Director, QCEIDAH
The University Of Queensland
Catatonia Assessment and Intervention in DSRD
9:35 - 10:00
Dr. Ryan Kammeyer
Crnic Institute For Down Syndrome Research
Deep Phenotyping and Sub-Clusters in DSRD
10:00 - 10:30
Dr. Jonathan Santoro
Director of Neuroimmunology
Children's Hospital Los Angeles and the Keck School of Medicine of the University of Southern California
Data from the First Randomized Clinical Trial for DS Therapies
10:30 - 11:00
Ms. Neetha Paul Eduthan
Bioinformatics Data Scientist
Linda Crnic Institute For Down Syndrome
Multiomics analysis and Biosignatures of Dysregulated Autoimmunity in DSRD
11:00 - 11:25
Dr. Jonathan Santoro
Director of Neuroimmunology
Children's Hospital Los Angeles and the Keck School of Medicine of the University of Southern California
Q&A
11:25 - 11:30
|
